Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact
Circulation
.
2011 Mar 15;123(10):1116-24.
doi: 10.1161/CIRCULATIONAHA.110.943860.
Authors
Mark J Pletcher
1
,
Michael Pignone
Affiliation
1
Department of Epidemiology, University of California, San Francisco, California, USA. mpletcher@epi.ucsf.edu
PMID:
21403122
PMCID:
PMC3138723
DOI:
10.1161/CIRCULATIONAHA.110.943860
No abstract available
Publication types
Review
MeSH terms
Biomarkers / analysis*
Evaluation Studies as Topic
Female
Humans
Male
Quality-Adjusted Life Years
Randomized Controlled Trials as Topic
Sample Size
Substances
Biomarkers
Grants and funding
K05 CA129166/CA/NCI NIH HHS/United States
R21 HL079276/HL/NHLBI NIH HHS/United States
R21 HL079276-02/HL/NHLBI NIH HHS/United States